Why Aptevo Therapeutics Is Trading Higher Today

Aptevo Therapeutics Inc APVO shares are trading higher on Tuesday, after the company announced it regained compliance with the NASDAQ listing requirements.

Aptevo Therapeutics is a clinical-stage biotechnology company, engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics in the U.S.

Aptevo Therapeutics shares were trading 8.24% higher at $4.07 on Tuesday. The stock has a 52-week high of $14.56 and a 52-week low of 27 cents.